Parallax Volatility Advisers, L.P. Abb Vie Inc. Transaction History

Parallax Volatility Advisers, L.P.

$42.9 Billion
Q2 2025

A detailed history of Parallax Volatility Advisers, L.P. transactions in Abb Vie Inc. stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 62,700 shares of ABBV stock, worth $14.4 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

62,700

Previous 2 3134900.0%

Holding current value

$14.4 Million

Previous $0 Infinity%

% of portfolio

0.03%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$169.2 - $216.66 $17.8 Million - $22.8 Million	-105,071 Reduced 100.0%	2 $0
Q4 2024 Feb 14, 2025	BUY	$164.99 - $203.87 $9.97 Million - $12.3 Million	60,447 Added 135.45%	105,073 $18.7 Million
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $1.87 Million - $2.28 Million	11,432 Added 34.44%	44,626 $8.81 Million
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $3.72 Million - $4.34 Million	24,012 Added 261.51%	33,194 $5.69 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $1.47 Million - $1.67 Million	9,182 New	9,182 $1.67 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $3.83 Million - $4.43 Million	28,649 New	28,649 $4.27 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $2.63 Million - $3.03 Million	-18,169 Reduced 35.11%	33,583 $5.35 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $4.39 Million - $5.27 Million	-31,754 Reduced 38.03%	51,752 $8.37 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $11.2 Million - $12.9 Million	83,506 New	83,506 $11.2 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $39.9 Million - $44 Million	-390,432 Reduced 84.65%	70,788 $7.66 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $33.2 Million - $44.8 Million	411,885 Added 834.87%	461,220 $49.4 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $7.36 Million - $8.64 Million	-85,719 Reduced 63.47%	49,335 $4.32 Million
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $71,535 - $95,725	-975 Reduced 0.72%	135,054 $13.3 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $7.84 Million - $11.9 Million	121,555 Added 839.82%	136,029 $10.4 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $1.04 Million - $1.3 Million	14,379 Added 15135.79%	14,474 $1.28 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $5.6 Million - $6.73 Million	-88,879 Reduced 99.89%	95 $7,000
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $4.59 Million - $5.87 Million	69,903 Added 366.54%	88,974 $6.47 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $18.1 Million - $21.4 Million	-235,202 Reduced 92.5%	19,071 $1.54 Million
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $19.8 Million - $24.4 Million	253,703 Added 44509.3%	254,273 $23.4 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $893,849 - $1.06 Million	-9,956 Reduced 94.58%	570 $53,000
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $2.46 Million - $3.29 Million	-26,714 Reduced 71.73%	10,526 $996,000
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $3.34 Million - $3.66 Million	37,240	37,240 $3.6 Million

Others Institutions Holding ABBV

# of Institutions

4,295

Shares Held

1.3B

Call Options Held

16.1M

Put Options Held

10.9M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $407B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Account

Parallax Volatility Advisers, L.P. Abb Vie Inc. Transaction History